PROCEPT BioRobotics Corp |
Director |
Common Stock |
197K |
$15.9M |
$80.65 |
Sep 12, 2024 |
By The 2:22 DNA Trust |
PROCEPT BioRobotics Corp |
Director |
Stock Option (Right to Buy) |
2.53K |
|
|
Jun 4, 2024 |
Direct |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Barred Owl Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CD Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CPMG, Inc. |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Crested Crane, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Elepaio Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Gallopavo, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Kestrel Fund, LP( |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Killdeer Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Mallard Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Managed Account for Trustees of the University of Pennsylvania |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Nighthawk Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Redbird Life Sciences Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Roadrunner Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Sandpiper Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By The 2:22 DNA Trust |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Willet Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Yellow Warbler, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CD Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CPMG, Inc. |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Kestrel Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Mallard Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Redbird Life Sciences Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Willet Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Yellow Warbler, LP |